The purpose of this study is to compare the safety and effectiveness of 2 treatments for thrush (a fungal infection of the mouth and throat) in HIV-positive patients. Fluconazole is a drug that is commonly used to treat thrush. SCH 56592 is a new drug that will be compared to fluconazole.
Patients receive SCH 56592 oral suspension or fluconazole suspension for 14 days. Patients remain on study for 44 days total and are monitored for safety and efficacy of study treatment.
Study Type
INTERVENTIONAL
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
300
East Bay AIDS Ctr
Berkeley, California, United States
ViRx Inc
San Francisco, California, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Kaiser Foundation Hospital
San Francisco, California, United States
Infectious Disease and AIDS Clinic
Denver, Colorado, United States
Dupont Circle Physicians Group
Washington D.C., District of Columbia, United States
Boulevard Comprehensive Care Ctr
Jacksonville, Florida, United States
Miami Veterans Administration Med Ctr
Miami, Florida, United States
TRIAD Health Practice
Chicago, Illinois, United States
Community Hosp Indianapolis
Indianapolis, Indiana, United States
Wayne State Univ / Harper Hosp
Detroit, Michigan, United States
...and 8 more locations